• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Carnival, SMART Global, Friedman Industries And Other Big Stocks Moving Higher On Friday

    6/30/23 10:27:33 AM ET
    $ACCD
    $ALVO
    $APPS
    $ARQT
    Business Services
    Consumer Discretionary
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $ACCD alert in real time by email

    U.S. stocks traded higher, with the Dow Jones gaining more than 200 points on Friday. Here are some big stocks recording gains in today’s session.

    • Addentax Group Corp. (NASDAQ:ATXG) shares gained 47.3% to $9.68. Addentax Group is launching automation of artificial intelligence internet operational tools project with top Games-as-a-Service firms.
    • CymaBay Therapeutics, Inc. (NASDAQ:CBAY) jumped 40% to $10.97.
    • TOP Financial Group Limited (NASDAQ:TOP) shares rose 32.2% to $10.31 after the company reported FY23 financial results.
    • Friedman Industries, Incorporated (NYSE:FRD) gained 19.6% to $11.90 after posting a profit for the fourth quarter.
    • Rackspace Technology, Inc. (NASDAQ:RXT) surged 15.8% to $2.27. Rackspace Technology partnered with Google Cloud to offer cutting-edge generative AI services and solutions using the FAIR practice.
    • MicroVision, Inc. (NASDAQ:MVIS) jumped 12.8% to $4.40.
    • XPeng Inc. (NYSE:XPEV) rose 12.4% to $13.29 after CLSA upgraded the stock from Buy to Outperform and raised the price target from $10 to $13.1. The company, on Thursday. launched G6 Ultra Smart Coupe SUV in China.
    • Alvotech (NASDAQ:ALVO) gained 12.2% to $7.74. The FDA issued a complete response letter to second application for AVT02, biosimilar candidate for Humira.
    • Digital Turbine, Inc. (NASDAQ:APPS) jumped 11.3% to $9.58.
    • Savara Inc. (NASDAQ:SVRA) gained 10% to $2.97.
    • Vitru Limited (NASDAQ:VTRU) rose 9.5% to $17.61.
    • Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) gained 9.4% to $9.12.
    • Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) shares climbed 9% to $9.98 after the board announced exploration of strategic alternatives to maximize shareholder value.
    • Accolade, Inc. (NASDAQ:ACCD) rose 8.4% to $13.71 after the company reported better than expected first-quarter earnings.
    • Bausch + Lomb Corporation (NYSE:BLCO) climbed 7.8% to $20.68 after the company announced it entered into a definitive agreement with Novartis to acquire XIIDRA.
    • Carnival Corporation (NYSE:CCL) gained 7.8% to $18.50 after Jefferies upgraded the stock from Hold to Buy and raised the price target from $9 to $25.
    • SMART Global Holdings, Inc. (NASDAQ:SGH) rose 7.7% to $28.69 after the company reported better-than-expected third-quarter financial results and issued guidance.
    • GoGreen Investments Corporation (NYSE:GOGN) gained 6.3% to $11.30 after the company announced shareholder approval of business combination with Lifezone Metals.
    • NIO Inc. (NYSE:NIO) rose 6.2% to $9.98.

     

    Read More: Top 3 Energy Stocks Which Could Rescue Your Portfolio This Month

    Get the next $ACCD alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACCD
    $ALVO
    $APPS
    $ARQT

    CompanyDatePrice TargetRatingAnalyst
    NIO Inc.
    $NIO
    1/15/2026$6.10Neutral → Outperform
    Macquarie
    Bausch + Lomb Corporation
    $BLCO
    1/5/2026$18.00Outperform → In-line
    Evercore ISI
    Bausch + Lomb Corporation
    $BLCO
    12/11/2025$20.00Neutral → Buy
    Citigroup
    Alvotech
    $ALVO
    12/9/2025$5.00Underweight
    Barclays
    Aurinia Pharmaceuticals Inc
    $AUPH
    12/3/2025$16.00Outperform → Market Perform
    Leerink Partners
    Bausch + Lomb Corporation
    $BLCO
    12/2/2025$21.00Equal-Weight → Overweight
    Morgan Stanley
    NIO Inc.
    $NIO
    11/25/2025Outperform → Neutral
    Macquarie
    Carnival Corporation
    $CCL
    11/18/2025$37.00Overweight
    Wells Fargo
    More analyst ratings

    $ACCD
    $ALVO
    $APPS
    $ARQT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Defining Wellness Centers Names Bill Morrison Chief Financial Officer

    Experienced Healthcare Executive Joins Leadership Team to Support Continued Growth Backed by Fulcrum Equity PartnersJACKSON, Miss., March 9, 2026 /PRNewswire/ -- Defining Wellness Centers (www.definingwellness.com) today announced that veteran healthcare executive Bill Morrison has joined the organization as Chief Financial Officer. Morrison brings more than 25 years of experience helping scale healthcare and behavioral health companies and will oversee the company's financial strategy during a period of continued growth backed by Atlanta-based growth equity firm Fulcrum Equity Partners.

    3/9/26 9:17:00 AM ET
    $ACCD
    Business Services
    Consumer Discretionary

    Bausch + Lomb Launches R&D "Teach-in" Webinar Series

    Bausch + Lomb Corporation (NYSE/TSX:BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the first event in an R&D "Teach-in" webinar series that will provide deeper insights on the company's differentiated product pipeline, which was unveiled in November 2025. On Monday, March 23, 2026, at 1:30 p.m. ET, Executive Vice President of Research & Development and Chief Medical Officer Yehia Hashad, MD, will be joined by members of his leadership team to discuss two glaucoma assets: BL1107, a glaucoma medication under development that would be the first to treat vision loss in addition to lowering intraocular pressure ELIOS™, an

    3/9/26 7:15:00 AM ET
    $BLCO
    Ophthalmic Goods
    Health Care

    Savara Provides Regulatory Update on the MOLBREEVI* Development Program in Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP)

    -- Day 74 Letter Received from the U.S. Food and Drug Administration (FDA) Indicated the Agency Has No Plans to Convene an Advisory Committee -- -- Company has Submitted the Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) -- -- Submission of the MAA to the U.K. Medicines and Healthcare Products Regulatory Agency (MHRA) Remains on Track by the End of Q1 2026 -- Savara Inc. (the "Company") (Nasdaq: SVRA), a clinical-stage biopharmaceutical company focused on rare respiratory diseases, today announced that it has received the Day 74 Letter from the FDA which indicated that an Advisory Committee meeting is not planned for the MOLBREEVI Biologics License Ap

    3/6/26 4:05:00 PM ET
    $SVRA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACCD
    $ALVO
    $APPS
    $ARQT
    SEC Filings

    View All

    SEC Form 10-K filed by Rackspace Technology Inc.

    10-K - Rackspace Technology, Inc. (0001810019) (Filer)

    3/6/26 4:07:05 PM ET
    $RXT
    Computer Software: Programming Data Processing
    Technology

    SEC Form 6-K filed by XPeng Inc.

    6-K - XPENG INC. (0001810997) (Filer)

    3/5/26 10:09:54 AM ET
    $XPEV
    Auto Manufacturing
    Industrials

    SEC Form 10-K filed by MicroVision Inc.

    10-K - MICROVISION, INC. (0000065770) (Filer)

    3/4/26 5:20:52 PM ET
    $MVIS
    Industrial Machinery/Components
    Technology

    $ACCD
    $ALVO
    $APPS
    $ARQT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President / CEO / Director Taylor Mike J bought $7,200 worth of shares (400 units at $18.00), increasing direct ownership by 0.18% to 222,666 units (SEC Form 4)

    4 - FRIEDMAN INDUSTRIES INC (0000039092) (Issuer)

    3/5/26 10:48:54 AM ET
    $FRD
    Steel/Iron Ore
    Industrials

    Chief Business Officer Akkerman Michael covered exercise/tax liability with 28,965 shares, decreasing direct ownership by 9% to 280,545 units (SEC Form 4)

    4 - Digital Turbine, Inc. (0000317788) (Issuer)

    3/4/26 4:52:25 PM ET
    $APPS
    Multi-Sector Companies
    Miscellaneous

    Director Ross Thomas W. Sr. bought $79,556 worth of shares (4,500 units at $17.68) and was granted 4,500 shares, increasing direct ownership by 15% to 69,391 units (SEC Form 4)

    4 - Bausch & Lomb Corp (0001860742) (Issuer)

    3/4/26 4:18:54 PM ET
    $BLCO
    Ophthalmic Goods
    Health Care

    $ACCD
    $ALVO
    $APPS
    $ARQT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President / CEO / Director Taylor Mike J bought $7,200 worth of shares (400 units at $18.00), increasing direct ownership by 0.18% to 222,666 units (SEC Form 4)

    4 - FRIEDMAN INDUSTRIES INC (0000039092) (Issuer)

    3/5/26 10:48:54 AM ET
    $FRD
    Steel/Iron Ore
    Industrials

    Director Ross Thomas W. Sr. bought $79,556 worth of shares (4,500 units at $17.68) and was granted 4,500 shares, increasing direct ownership by 15% to 69,391 units (SEC Form 4)

    4 - Bausch & Lomb Corp (0001860742) (Issuer)

    3/4/26 4:18:54 PM ET
    $BLCO
    Ophthalmic Goods
    Health Care

    Director Tang Kevin bought $12,688,806 worth of shares (900,000 units at $14.10) (SEC Form 4)

    4 - Aurinia Pharmaceuticals Inc. (0001600620) (Issuer)

    3/3/26 5:35:12 PM ET
    $AUPH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACCD
    $ALVO
    $APPS
    $ARQT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    NIO upgraded by Macquarie with a new price target

    Macquarie upgraded NIO from Neutral to Outperform and set a new price target of $6.10

    1/15/26 2:18:27 PM ET
    $NIO
    Auto Manufacturing
    Industrials

    Bausch + Lomb downgraded by Evercore ISI with a new price target

    Evercore ISI downgraded Bausch + Lomb from Outperform to In-line and set a new price target of $18.00

    1/5/26 8:46:17 AM ET
    $BLCO
    Ophthalmic Goods
    Health Care

    Bausch + Lomb upgraded by Citigroup with a new price target

    Citigroup upgraded Bausch + Lomb from Neutral to Buy and set a new price target of $20.00

    12/11/25 8:44:49 AM ET
    $BLCO
    Ophthalmic Goods
    Health Care

    $ACCD
    $ALVO
    $APPS
    $ARQT
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for SELARSDI issued to ALVOTECH USA INC

    Submission status for ALVOTECH USA INC's drug SELARSDI (SUPPL-2) with active ingredient USTEKINUMAB-AEKN has changed to 'Approval' on 10/18/2024. Application Category: BLA, Application Number: 761343, Application Classification:

    10/21/24 10:44:05 PM ET
    $ALVO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for SELARSDI issued to ALVOTECH USA INC

    Submission status for ALVOTECH USA INC's drug SELARSDI (SUPPL-1) with active ingredient USTEKINUMAB-AEKN has changed to 'Approval' on 10/18/2024. Application Category: BLA, Application Number: 761343, Application Classification:

    10/21/24 2:59:28 PM ET
    $ALVO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for SELARSDI issued to ALVOTECH USA INC

    Submission status for ALVOTECH USA INC's drug SELARSDI (SUPPL-3) with active ingredient USTEKINUMAB-AEKN has changed to 'Approval' on 10/18/2024. Application Category: BLA, Application Number: 761343, Application Classification:

    10/21/24 2:59:28 PM ET
    $ALVO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ACCD
    $ALVO
    $APPS
    $ARQT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Savara Inc.

    SC 13G - Savara Inc (0001160308) (Subject)

    11/27/24 11:01:58 AM ET
    $SVRA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Arcutis Biotherapeutics Inc.

    SC 13G/A - Arcutis Biotherapeutics, Inc. (0001787306) (Subject)

    11/14/24 7:50:59 PM ET
    $ARQT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Accolade Inc.

    SC 13G/A - Accolade, Inc. (0001481646) (Subject)

    11/14/24 7:34:26 PM ET
    $ACCD
    Business Services
    Consumer Discretionary

    $ACCD
    $ALVO
    $APPS
    $ARQT
    Leadership Updates

    Live Leadership Updates

    View All

    Defining Wellness Centers Names Bill Morrison Chief Financial Officer

    Experienced Healthcare Executive Joins Leadership Team to Support Continued Growth Backed by Fulcrum Equity PartnersJACKSON, Miss., March 9, 2026 /PRNewswire/ -- Defining Wellness Centers (www.definingwellness.com) today announced that veteran healthcare executive Bill Morrison has joined the organization as Chief Financial Officer. Morrison brings more than 25 years of experience helping scale healthcare and behavioral health companies and will oversee the company's financial strategy during a period of continued growth backed by Atlanta-based growth equity firm Fulcrum Equity Partners.

    3/9/26 9:17:00 AM ET
    $ACCD
    Business Services
    Consumer Discretionary

    Digital Turbine Appoints Ben John as Chief Technology Officer

    The seasoned AI, Data, and AdTech veteran joins DT from Microsoft AI Copilot to help lead the next phase of innovation, building on continuous momentum and performanceAUSTIN, Texas, Feb. 25, 2026 /PRNewswire/ -- Digital Turbine, the global leader in growth solutions for the mobile ecosystem, is excited to announce the appointment of Ben John as the company's Chief Technology Officer. Joining the company at a period of accelerating growth, Ben will lead DT's global engineering, product architecture, data-first scaling, and AI-driven development to support its momentum.Digital Turbine appoints Microsoft AI executive Ben John, an AI, Data, and AdTech veteran, as Chief Technology Officer.Ben's c

    2/25/26 8:55:00 AM ET
    $APPS
    Multi-Sector Companies
    Miscellaneous

    Joseph Vito Joins Rackspace Technology to Lead Strategic Alliance Partnerships

    SAN ANTONIO, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Rackspace Technology® (NASDAQ:RXT), a leading end-to-end hybrid cloud and AI solutions company, today announced the appointment of Joseph Vito as Senior Vice President of Strategic Alliance Partnerships. In this role, Vito will lead Rackspace's global strategy for building and strengthening technology and channel partnerships that drive innovation and deliver exceptional value to customers. Vito brings more than 25 years of experience in technology leadership, cloud transformation, and enterprise solutions across financial services, life sciences, energy, and consumer manufacturing. Most recently, he served as a Strategic Transformation Princ

    1/27/26 8:15:00 AM ET
    $RXT
    Computer Software: Programming Data Processing
    Technology

    $ACCD
    $ALVO
    $APPS
    $ARQT
    Financials

    Live finance-specific insights

    View All

    XPENG to Report Fourth Quarter and Fiscal Year 2025 Financial Results on Friday, March 20, 2026

    - Earnings Call Scheduled for 8:00 a.m. ET on March 20, 2026 -GUANGZHOU, China, March 5, 2026 /PRNewswire/ -- XPeng Inc. ((", XPENG", or the ", Company, ", NYSE:XPEV), a leading global AI mobility technology company, today announced that it will report its fourth quarter and fiscal year 2025 unaudited financial results on Friday, March 20, 2026, before the open of U.S. markets. The Company's management will host an earnings conference call at 8:00 AM U.S. Eastern Time on March 20, 2026 (8:00 PM Beijing/Hong Kong Time on March 20, 2026).For participants who wish to join the call by phone, please access the link provided below to complete the pre-registration and dial in 5 minutes prior to the

    3/5/26 4:00:00 AM ET
    $XPEV
    Auto Manufacturing
    Industrials

    Alvotech to Report Fourth Quarter and Full Year 2025 Financial Results

    REYKJAVIK, Iceland, March 04, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ:ALVO) (the "Company"), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that it will release its fourth quarter and full year 2025 financial and operating results on Wednesday, March 18, 2026, after the U.S. markets close. The Company will also host a conference call with a live Q&A on Thursday, March 19, 2026 at 08:00 EST (12:00 GMT, 13:00 CET). To listen to the webcast, register here: Q4 and Full Year 2025 webcast registrationTo participate in the Q&A, register here: Q4 and Full Year 2025 conference call registration Slid

    3/4/26 3:00:00 AM ET
    $ALVO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Rackspace Technology Reports Fourth Quarter and Full Year 2025 Results

    Fourth Quarter Revenue of $683 million, down 0.4% Year-over-Year; 2025 Revenue of $2,686 million, down 2% Year-over-YearFourth Quarter Private Cloud Revenue of $241 million, down 10% Year-over-Year; 2025 Private Cloud Revenue of $990 million, down 6% Year-over-YearFourth Quarter Public Cloud Revenue of $442 million, up 6% Year-over-Year; 2025 Public Cloud Revenue of $1,696 million up 1% Year-over-YearFourth Quarter Cash Flow From Operating Activities of $60 million; 2025 Cash Flow From Operating Activities of $151 million SAN ANTONIO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Rackspace Technology, Inc. (NASDAQ:RXT), a leading end-to-end hybrid cloud and AI solutions company, today announc

    2/26/26 8:00:00 AM ET
    $RXT
    Computer Software: Programming Data Processing
    Technology